Request a Proposal  

News

Pharm-Olam is singularly committed to optimizing every aspect of a clinical trial across all functional areas. We have enrolled thousands of patients in planned studies and have been frequently enlisted for rescue studies, assistance with data protection and US federal funding for clinical research.

Blog Feature

By: Admin
November 13th, 2014

The Ukraine has been a hot topic in the news due to the recent turmoil in the country. Even during these difficult times, drug development and clinical trials continue to be run in the Ukraine, which boasts recruitment figures at least two times higher than those in the United States and Western Europe. To view a recording of this webinar, click here

Blog Feature

By: Admin
November 4th, 2014

HOUSTON, TEXAS - November 4th, 2014. Pharm-Olam International Ltd., a multi-national, full-service CRO to biopharmaceutical and device industries is proud to celebrate 20 years of successfully helping our sponsors create a healthier world.

GDPR_Checklist-cover

Join other Clinical Development experts to get the latest industry news, trends and insights.

As a thank you for subscribing, you'll receive a free copy of our GDPR Controller & Processor Checklist

Blog Feature

By: Admin
February 1st, 2014

Pharm-Olam was contracted to provide a full-service solution for two Phase II, dose escalation allergy studies that required a total of 500 patients in Europe. With two different allergy indications, Grass Pollen and Birch Pollen, these studies presented some unique challenges.

Blog Feature

By: Admin
January 13th, 2014

In our continued quest to reduce time and effort to bring medicines to market; Pharm-Olam is pleased to announce expansion into Israel. Pharm-Olam continues to look to increase its strategic footprint to offer our clients a greater choice to support their clinical trials. Incorporating Israel into your clinical trials offers you several benefits including:

Blog Feature

By: Admin
May 30th, 2013

HOUSTON, TX – Pharm-Olam International Ltd. a multi-national, full service provider of outsourced development services to the pharmaceutical and biotech industries, announced its successful expansion of clinical trial services into Kazakhstan.